These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17486433)

  • 61. Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement.
    Brousseau G; Rourke BP; Burke B
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):546-54. PubMed ID: 18179307
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of Alzheimer's disease with cholinergic drugs.
    Kumar V; Calache M
    Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):23-37. PubMed ID: 2004862
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alzheimer's dementia: current data review.
    Uzun S; Kozumplik O; Folnegović-Smalc V
    Coll Antropol; 2011 Dec; 35(4):1333-7. PubMed ID: 22397284
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Memory enhancing drugs and Alzheimer's disease: enhancing the self or preventing the loss of it?
    Dekkers W; Rikkert MO
    Med Health Care Philos; 2007 Jun; 10(2):141-51. PubMed ID: 17486433
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Do antidepressants affect the self? A phenomenological approach.
    Svenaeus F
    Med Health Care Philos; 2007 Jun; 10(2):153-66. PubMed ID: 17476581
    [TBL] [Abstract][Full Text] [Related]  

  • 67. What is a genetic cause? The example of Alzheimer's Disease.
    Dekkers W; Rikkert MO
    Med Health Care Philos; 2006; 9(3):273-84. PubMed ID: 16847726
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Constructions of self: ethical overtones in surprising locations.
    Kinsella EA
    Med Humanit; 2005 Dec; 31(2):67-71. PubMed ID: 16425481
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human agency in the neurocentric age. Philosophers and scientists resort to dualistic explanations to reconcile the age-old dichotomy between determinism and 'free will', but agency is an integral part of human biology.
    Rose SP
    EMBO Rep; 2005 Nov; 6(11):1001-5. PubMed ID: 16264421
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vitamin E and donepezil for the treatment of mild cognitive impairment.
    Petersen RC; Thomas RG; Grundman M; Bennett D; Doody R; Ferris S; Galasko D; Jin S; Kaye J; Levey A; Pfeiffer E; Sano M; van Dyck CH; Thal LJ;
    N Engl J Med; 2005 Jun; 352(23):2379-88. PubMed ID: 15829527
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Eric Kandel: the future of memory.
    Kandel E
    Mol Interv; 2005 Apr; 5(2):65-9. PubMed ID: 15821153
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neuropsychological test performance in healthy elderly volunteers before and after donepezil administration: a randomized, controlled study.
    Beglinger LJ; Tangphao-Daniels O; Kareken DA; Zhang L; Mohs R; Siemers ER
    J Clin Psychopharmacol; 2005 Apr; 25(2):159-65. PubMed ID: 15738747
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neuroethics: the practical and the philosophical.
    Farah MJ
    Trends Cogn Sci; 2005 Jan; 9(1):34-40. PubMed ID: 15639439
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ageless bodies, happy souls: biotechnology and the pursuit of perfection.
    Kass LR
    New Atlantis; 2003; (1):9-28. PubMed ID: 15584192
    [No Abstract]   [Full Text] [Related]  

  • 75. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis.
    Heyn P; Abreu BC; Ottenbacher KJ
    Arch Phys Med Rehabil; 2004 Oct; 85(10):1694-704. PubMed ID: 15468033
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cosmetic neurology: the controversy over enhancing movement, mentation, and mood.
    Chatterjee A
    Neurology; 2004 Sep; 63(6):968-74. PubMed ID: 15452285
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cognition-enhancing drugs.
    Mehlman MJ
    Milbank Q; 2004; 82(3):483-506, table of contents. PubMed ID: 15330974
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Monitoring and manipulating brain function: new neuroscience technologies and their ethical implications.
    Farah MJ; Wolpe PR
    Hastings Cent Rep; 2004; 34(3):35-45. PubMed ID: 15281725
    [No Abstract]   [Full Text] [Related]  

  • 79. Neuropsychological test performance in healthy volunteers before and after donepezil administration.
    Beglinger LJ; Gaydos BL; Kareken DA; Tangphao-Daniels O; Siemers ER; Mohs RC
    J Psychopharmacol; 2004 Mar; 18(1):102-8. PubMed ID: 15107192
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.